SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-18-001970
Filing Date
2018-02-28
Accepted
2018-02-28 17:04:46
Documents
36
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A oxis_10q.htm 10-Q/A 520914
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF oxis_ex311.htm EX-31.1 18060
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF oxis_ex312.htm EX-31.2 17939
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE oxis_ex321.htm EX-32.1 7101
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE oxis_ex322.htm EX-32.2 7155
  Complete submission text file 0001654954-18-001970.txt   1844629

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gtbp-20160331.xml EX-101.INS 204372
7 XBRL TAXONOMY EXTENSION SCHEMA gtbp-20160331.xsd EX-101.SCH 18747
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gtbp-20160331_cal.xml EX-101.CAL 33718
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gtbp-20160331_def.xml EX-101.DEF 40672
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gtbp-20160331_lab.xml EX-101.LAB 151658
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gtbp-20160331_pre.xml EX-101.PRE 116141
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-08092 | Film No.: 18652358
SIC: 2834 Pharmaceutical Preparations